Last Updated: November 8, 2026

CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER Drug Patent Profile

Name: CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Cefotaxime And Dextrose 2.4% In Plastic Container, and what generic alternatives are available?

Cefotaxime And Dextrose 2.4% In Plastic Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER is cefotaxime sodium. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the cefotaxime sodium profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER?
What are the global sales for CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER?
What is Average Wholesale Price for CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER?

Summary for CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	36
Clinical Trials:	40
DailyMed Link:	CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER at DailyMed

Drug patent expirations by year for CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER

Recent Clinical Trials for CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
The Swedish Research Council	PHASE4
Uppsala University	PHASE4
Uppsala Clinical Research Center, Sweden	PHASE4

See all CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER	cefotaxime sodium	INJECTABLE;INJECTION	050792-001	Jul 29, 2004		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.